Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell receptor beta variable 7-1 pseudogene (TRBV7-1)
- Target
- TRBV7-1
- Molecular classification
- Pseudogene, Immunoglobulin superfamily (variable region), Non-functional T cell receptor
01
Overview
T cell receptor beta variable 7-1 pseudogene (TRBV7-1) is classified as a predicted non-functional open reading frame within the V region of the T cell receptor beta chain[1]. Unlike functional TRBV genes, TRBV7-1 is unable to undergo productive V-(D)-J recombination and/or proper mRNA splicing required for expression of a functional receptor. As a result, TRBV7-1 cannot contribute to the functional diversity or antigen recognition capability of T cell receptors. While many TRBV pseudogenes are present in the human genome, their biological functions remain largely undetermined, although their rearrangements can be observed in very low frequency within the TCR repertoire, particularly in certain disease contexts[4]. The principal role of functional T cell receptors is antigen recognition and adaptive immunity, but TRBV7-1 does not participate in these processes due to its non-functionality.
- Other names
- TRBV7-1TRBV71TCRBV6S7PTCRBV7S1T cell receptor beta variable 7-1 pseudogene
02
Mechanism of action
None (not targeted by drugs or therapies)
03
Biological functions
No known direct biological function (unable to form productive TCR beta chains)the canonical TCR beta variable region is crucial for antigen recognition and immune response, but the pseudogene does not produce a functional receptor
04
Disease associations
No direct rolesome studies have investigated whether pseudogene rearrangements are detectable in disease states (e.g., leukemia), but their biological relevance remains unclear
05
Safety considerations
Noneas a pseudogene, there are no therapeutic or clinical safety concerns directly attributed to TRBV7-1
06
Interacting drugs
None (pseudogenes are not drug targets; no known drugs interact with TRBV7-1)
07
Biomarkers
None specific to TRBV7-1functional TCR beta chain regions—including productive rearrangements—are relevant in immunoprofiling, but not pseudogene variants
Beyond the preview
Go deeper on T cell receptor beta variable 7-1 pseudogene (TRBV7-1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on T cell receptor beta variable 7-1 pseudogene (TRBV7-1).